सभी अध्ययन
सक्रिय लेकिन भर्ती नहींNAहस्तक्षेपात्मक

A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease

This study aims to understand more about late-onset Pompe disease in people over 16. Researchers are looking at certain substances in the blood, called biomarkers, that provide information about the disease. They also want to measure antibody levels against a specific enzyme (GAA) and a common virus (AAV) used in gene therapy. This is important because antibodies can affect how well treatments work. Participants will have blood and urine tests over two years, but no new treatments will be given. The findings will help improve future ways to diagnose and treat Pompe disease.

एक नजर में

स्थिति
सक्रिय लेकिन भर्ती नहीं
चरण
NA
प्रायोजक
Astellas Gene Therapies
नामांकन लक्ष्य
119
प्रारंभ
01 Feb 2024
अनुमानित पूर्णता
30 जून 2027

यह अध्ययन किस बारे में है?

Pompe disease is a condition you are born with that causes muscles to become weaker over time. This happens because a special enzyme called GAA doesn't work correctly, leading to a build-up of a sugar called glycogen in your body's cells. Late-onset Pompe disease usually starts affecting people from about 12 months old onwards.

Currently, many people with Pompe disease receive regular infusions of the missing GAA enzyme, which is called enzyme replacement therapy. However, over time, some people's bodies might make special proteins called antibodies against this enzyme, which could make the treatment less effective. Scientists are also exploring a new treatment called gene therapy. This involves replacing the faulty gene with a working one, often using a harmless virus (like AAV) to carry the new gene into the cells. If you've had a natural infection with a similar virus before, you might have antibodies against it, which could stop the gene therapy from working well.

This study wants to learn more about the levels of these antibodies in people with late-onset Pompe disease. They also want to find other important substances in the blood, called biomarkers, that can give doctors more information about how the disease is progressing. By understanding these levels, researchers hope to improve how Pompe disease is diagnosed and treated in the future.

मुख्य निष्कर्ष

  • Learn more about late-onset Pompe disease.
  • No new treatments given in this study.
  • Involves regular blood and urine tests over two years.
  • Helps understand how bodies react to existing or future treatments.
  • Ages 16-69 with late-onset Pompe disease can take part.
  • Your participation helps future research.

कौन पात्र हो सकता है?

This study is looking for people aged between 16 and 69 who have been diagnosed with late-onset Pompe disease. You could be considered if you have never had enzyme replacement therapy (ERT), or if you have been receiving ERT for at least six months.

However, you cannot take part if you have ever had gene therapy or any other treatment using an AAV-related product. You also cannot join if you are already in another Pompe disease study that involves a new treatment (unless it's an ERT study) or if you need breathing support while you are awake and sitting or standing up. You must also be able to walk, even if you use a walking aid like a cane.

It's important that you are willing and able to come to the study visits as required. Also, while you are in this study, you cannot start any new clinical study that involves a different medication, including new enzyme replacement therapies.

क्या यह अध्ययन आपके लिए उपयुक्त हो सकता है?

यह देखने के लिए इन त्वरित प्रश्नों का उत्तर दें कि क्या आप पात्र हो सकते हैं। यह केवल एक मार्गदर्शिका है — अंतिम निर्णय शोध टीम द्वारा लिया जाता है।.

  1. Have you been diagnosed with late-onset Pompe disease?
  2. क्या आपकी उम्र 16 से 69 वर्ष के बीच है?
  3. Have you *never* received gene therapy or any AAV-related treatment?
  4. Are you either not currently on enzyme replacement therapy, or have you been on it for at least 6 months?
  5. Can you walk, even if you use a walking aid?
  6. Are you able to attend study visits as required?
अपने परिणाम देखने के लिए हर प्रश्न का उत्तर दें।.

भागीदारी में क्या शामिल है?

If you decide to take part in this study, you will have several visits to a study clinic, and some visits might even be at your own home. The first visit is to check if you are suitable for the study. If you are, you will have a medical check-up, and your 'vital signs' will be recorded. Vital signs include things like your blood pressure, heart rate, breathing rate, and temperature.

During the study, you won't be given any new treatments or medicines. Instead, the main part of your involvement will be giving blood and urine samples. These samples will be tested for antibody levels against the GAA enzyme and against the AAV8 virus. They will also be checked for those important biomarkers related to Pompe disease. You'll need to provide these blood and urine samples roughly every four months for up to two years. You can choose to leave the study at any time.

संभावित जोखिम और लाभ

There are no direct benefits to your health from taking part in this study as no new treatments are given. However, your participation will help doctors and scientists understand late-onset Pompe disease better, which could lead to improved care and treatments for others in the future. The main risks involve the discomfort and potential bruising from blood draws, as with any blood test. You have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

स्थान (53)

  • Emory Clinic
    सत्यापित पोस्टकोड
    अटलांटा, संयुक्त राज्य अमेरिका
  • कैनसस विश्वविद्यालय चिकित्सा केंद्र
    सत्यापित पोस्टकोड
    कैनसस सिटी, संयुक्त राज्य अमेरिका
  • मिशिगन विश्वविद्यालय
    सत्यापित पोस्टकोड
    ऐन आर्बर, संयुक्त राज्य अमेरिका
  • Children's Hospitals and Clinics of Minnesota
    सत्यापित पोस्टकोड
    मिनियापोलिस, संयुक्त राज्य अमेरिका
  • Hackensack University Medical Center
    सत्यापित पोस्टकोड
    हैकेंसैक, संयुक्त राज्य अमेरिका
  • University of Cincinnati
    सत्यापित पोस्टकोड
    सिनसिनाटी, संयुक्त राज्य अमेरिका
  • पेंसिल्वेनिया विश्वविद्यालय
    सत्यापित पोस्टकोड
    फिलाडेल्फिया, संयुक्त राज्य अमेरिका
  • University of Pittsburgh Medical Center
    सत्यापित पोस्टकोड
    Pittsburgh, United States
  • University of UTAH - PPDS
    सत्यापित पोस्टकोड
    सॉल्ट लेक सिटी, संयुक्त राज्य अमेरिका
  • Lysosomal and Rare Diseases Research and Treatment Center, Inc.
    सत्यापित पोस्टकोड
    फेयरफैक्स, संयुक्त राज्य अमेरिका
  • AU61003
    सत्यापित पोस्टकोड
    एडिलेड, ऑस्ट्रेलिया
  • AU61001
    सत्यापित पोस्टकोड
    Herston, Australia

सामान्य प्रश्न

What is late-onset Pompe disease?

It's a genetic condition causing gradual muscle weakness, usually starting from age one year or older, due to a missing or faulty enzyme.

क्या मुझे इस अध्ययन में नया उपचार मिलेगा?

No, this study does not involve giving any new treatments. It's an 'observational' study, meaning doctors are just observing and collecting information.

What are 'antibodies' and why are they important?

Antibodies are proteins made by your body's immune system. In this study, researchers are checking if your body has made antibodies against the GAA enzyme (treatment) or against a virus (used in gene therapy), which could affect how well treatments work.

'बायोमार्कर्स' क्या हैं?

Biomarkers are substances in your blood or urine that can give doctors information about your health or about a disease, helping them track its progress.

मैं अध्ययन में कितने समय तक रहूँगा?

The study will last for about two years, with visits roughly every four months for blood and urine collections.

और अधिक जानने के लिए कैसे पता करें

किसी अध्ययन में भाग लेने का निर्णय लेने से पहले हमेशा अपने जीपी या विशेषज्ञ से बात करें।.

चर्चा

समुदाय चर्चा

हमारे फोरम द्वारा संचालित community.patient.info. कृपया सम्मानजनक रहें — यह चिकित्सा सलाह नहीं है।.